Oppenheimer upgraded Nektar (NKTR) to Outperform from Perform with a $6 price target The firm is refreshing its model ahead of the company’s ...

Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...

According to data from TV and streaming ad measurement firm iSpot, ads for "Oppenheimer" led the field among 2024 Oscars best picture nominees, with $25.7 million in estimated national TV media ...

Oppenheimer Holdings, Inc. engages as a middle-market investment bank and full-service broker-dealer. It operates through the following segments: Private Client, Asset Management, Capital Markets ...

Following the shock news that Amazon has taken full creative control over James Bond, with long-term 007 producers Barbara Broccoli and Michael G Wilson stepping back, a new report has shed light on ...

Investing.com -- Oppenheimer analysts recently engaged with investors to discuss their outlook on IBM (NYSE:IBM), addressing key questions about software growth, consulting revenue, and valuation ...

Oppenheimer's Annual Healthcare Life Sciences ... Annovis is dedicated to addressing neurodegeneration in diseases such as AD and PD. The Company is committed to developing innovative therapies ...